Skip to main content
AEHRAehr Test SystemsSell5.2·$55.31
AEHR · Concentration risk · 10-K extracted

Aehr Test Systems (AEHR) concentration risks

Updated

The most significant concentration Aehr Test Systems discloses is five largest customers at 70%, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: Aehr Test Systems’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 2 disclosed concentrations

HIGH2
MEDIUM0
LOW0
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

HIGHOutside partyCustomer
70%

five largest customers

“10-K Item 1A: 'Sales to our five largest customers accounted for approximately 70%, 77%, and 93% of our net sales in fiscal 2026, 2025, and 2024, respectively.'”
— SEC 10-K · filed Jul 2026
HIGHBuilt-inProduct / Revenue mix
63%

full wafer contact product lines

“10-K Item 1: 'Net revenues of full wafer contact product lines, systems, WaferPak Contactors and services ... accounted for approximately 63%, 66%, and 98%'”
— SEC 10-K · filed Jul 2026
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-10-18

Aehr's disclosed exposures are concentrated on both the customer and the product side, and the two reinforce each other. Sales to the five largest customers were approximately 70% of net sales, down from 77% and 93% in the two prior fiscal years. That is a large-share exposure and a dependency in character: the loss or delay of an order from any one of a handful of buyers would register directly in reported revenue. The product mix is the structural counterpart. Full wafer contact product lines, systems, WaferPak Contactors and services accounted for approximately 63% of net revenues, compared with 66% and 98% earlier. The filing's own trend shows the business broadening away from a single franchise, yet that franchise still carries most of the revenue. Netted together, customer dependency is the idiosyncratic risk that could move the verdict quickly, while product concentration is a slower-moving structural feature of the company's niche. The declining percentages in both disclosures are encouraging, but both exposures remain large in share.

For the engine’s reasoning on AEHR’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Semiconductor Equipment & Materials

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
ACLSAxcelis Technologies, Inc.3104
ACMRACM Research, Inc.3003
AMBAAmbarella, Inc.3003
AMATApplied Materials, Inc.2024
AEHR●Aehr Test Systems2002
AMKRAmkor Technology, Inc.1203

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home › Stocks › AEHR › Concentration risk